Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

Targeted drug shows promise for people with advanced bowel cancer in early trial - One patient taking part in the trial said the therapy has given her a ‘new lease of life’.

Juliet Fielder, a non-smoker, died on Friday, May 22 after being diagnosed with stage 4 lung cancer in 2021 Over the past few ...

Why does timely cancer screening matter? A renowned oncologist explains how timely medical intervention in cancer treatment ...

A non-smoker who was diagnosed with lung cancer at 37 has died aged 42. Juliet Fielder, known as Jules, from Hastings, East ...

The foundation stone for a new state-of-the-art cancer centre at the NHS Royal Sussex County Hospital in Brighton was laid on ...

A significant number of cancer patients—particularly those with more advanced cancers who are more likely to receive care at community hospitals, safety net hospitals, and rural medical centers—may ...

Avoiding sunbeds and wearing a hat changed everything for two people who have experienced the life-changing impact of skin ...

Sam was diagnosed in 2015 at the age of 14. With medical advancements, a supportive community and his strong faith, Sam ...

People have been shocked at how fast I've "recovered" and said I look "totally normal again," whatever that's supposed to ...

A consultant at the centre of a breast cancer care scandal has lost his bid to resume his clinical practice. Last year the ...